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ABSTRACT 
Production of an Antibiotic-like Activity by Streptomyces sp. COUK1 under Different Growth 
Conditions 
by 
Olaitan Akintunde 
Streptomyces are known to produce a large variety of antibiotics and other bioactive 
compounds with remarkable industrial importance. Streptomyces sp. COUK1 was found as a 
contaminant on a plate in which Rhodococcus erythropolis was used as a test strain in a disk 
diffusion assay and produced a zone of inhibition against the cultured R. erythropolis. The 
identity of the contaminant was confirmed as Streptomyces through 16S rRNA sequencing. This 
Streptomyces produces a strong inhibitory compound in different growth media. A culture 
extract from inorganic salts starch agar was found to be very active; producing a large zone of 
inhibition against several Gram positive and Gram negative test strains. The active molecules in 
this extract have been detected via TLC and bioautography. The difference in the antibacterial 
activity and chromatographic properties of extracts recovered from different growth media 
suggests that this Streptomyces strain could produce more than one type of inhibitory 
compound. 
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CHAPTER 1 
INTRODUCTION  
Antibiotic Resistance 
Many new antibiotics were identified in the 20 years from the late 1940s to the late 
1960s, most isolated from the actinomycetes. Some of these compounds became successful 
drugs and the pharmaceutical industry flourished. The rate of antibiotic discovery then declined 
sharply, so these productive years came to be called the Golden Age. Most bacterial pathogens 
were brought under control, but increased use of antibiotics also led to a dramatic rise in 
antibiotic resistance as these pathogenic bacteria evolved resistance. It became clear that 
antibiotic discovery was not over but rather an ongoing quest to find new treatments for old 
infections (Hopwood 2007). 
According to the Centers for Disease Control (CDC) threat report of 2013 at least 2 
million people are infected with antibiotic resistant bacteria each year in the United States and 
about 23,000 people die each year from these infections (CDC 2013). 
Importance of Natural Products 
Natural products are a substance of natural origin. They include (1) an entire organism 
(e.g., plant, animal or microorganism that has not been subject to processing or preservation, 
(2) part of an organism (e.g., leaves or flowers of a plant), (3) an extract of an organism or part 
of an organism and exudates, and (4) pure compounds (e.g., alkaloids, coumarins, flavonoids, 
glycosides, lignans, steroids, terpenoids) isolated from plants, animals, or microorganisms 
(Sarker et al. 2006). However, in most cases the term natural product refers to secondary 
metabolites, i.e., small molecules (molecular weight <2000 Dalton) produced by an organism 
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(e.g. plant, animal, or microorganism) that are not strictly required for the survival of the 
organism (Sarker et al. 2006). Natural products can be from any terrestrial or marine source: 
plants (e.g., paclitaxel (Taxol) from Taxus brevifolia), animals (e.g., vitamins A and D from cod 
liver oil), or microorganisms (e.g., doxorubicin from Streptomyces peucetius) (Sarker et al. 
2006). 
Natural products have been used as therapeutic agents for thousands of years and a 
large number of modern drugs have been derived from natural sources, many based on their 
use in traditional medicine. In recent years there has been a renewed interest in natural 
products as a potential source for new medicines among academia as well as pharmaceutical 
companies (Sarker et al. 2006).  
Approximately 40% of the modern drugs in use have been developed from natural 
products. More precisely 39% of the 520 new approved drugs between 1983 and 1994 were 
natural products or their derivatives, and 60–80% of antibacterial and anticancer drugs were 
from natural origins (Sarker et al. 2006). In 2000 approximately 60% of all drugs in clinical trials 
for a multiplicity of cancers had natural origins. In 2001 eight of the 30 top-selling drugs (i.e. 
simvastatin, pravastatin, amoxycillin, clavulanic acid, azithromycin, ceftriaxone, cyclosporine, 
and paclitaxel) were natural products or their derivatives, and these 8 drugs together totaled 
US $16 billion in sales (Sarker et al. 2006). 
Only a small fraction of the world’s biodiversity has been explored for bioactivity to 
date. For example, only about 5 – 10% of at least 250,000 species of higher plants have been 
examined (Sarker et al. 2006). 
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Much less is known about marine organisms than other sources of natural products. 
However, research up to now has shown that they represent a valuable source for novel 
bioactive compounds. With the development of new molecular targets, there is an increasing 
demand for novel molecular diversity for screening and natural products will certainly play a 
crucial role in meeting this demand through the continued investigation of the world’s 
biodiversity, much of which is yet to be explored (Sarker et al. 2006). With less than 1% of the 
microbial world currently known, advances in technologies for microbial cultivation and the 
extraction of nucleic acids from environmental samples from soil and marine habitats will offer 
access to an untapped reservoir of genetic and metabolic diversity (Sarker et al. 2006). 
Actinomycetes and Natural Products 
Actinomycetes are a taxonomic group of bacteria that are responsible for most 
antibiotics used today. They account for 45% of the 22,500 biologically active compounds that 
have been identified from microorganisms (Demain and Sanchez 2009).  
Most antibiotics in clinical use are direct natural products or semisynthetic derivatives 
from actinomycetes or fungi. Many of those products, including erythromycin and derivatives, 
vancomycin and teicoplanin, cephalosporins, rifamicin, tetracyclines, and daptomycin, were 
discovered through whole-cell antibacterial screening procedures (Baltz 2007).  
It has been estimated that the top 10 cm of global soil contains 1025-1026 actinomycetes, 
but only about 107 have been screened for antibiotic production in the past 50 years, leaving 
plenty of room for further screening (Baltz 2007). 
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Genus Streptomyces 
Taxonomic History 
The genus Streptomyces was proposed by Waksman and Henricii (1943) and was placed 
in the family Streptomycetaceae on the basis of morphology and cell wall properties. 
Incorporation of molecular biology into classification changed early numerical systems using 
phenotypic characters (Anderson and Wellington 2001). Stackebrandt et al. (1997) proposed a 
classification system in which phylogenetically neighboring taxa at the genus level are clustered 
into families, suborders (related organisms ranking between order and family), orders 
(comprise of related families), subclasses (related organisms ranking between class and order), 
and a class (comprised of related orders) using 16S rDNA phylogenetic analysis and the 
presence of taxon-specific 16S rDNA signature nucleotides regardless of the phenotypic 
properties used in describing the taxa in the past. For example, prior to this, Streptomyces and 
Streptoverticillium were 2 separate genera (Anderson and Wellington 2001). Members of 
Streptoverticillium were later linked to the Streptomyces lavendulae species group through 
immunodiffusion assay (Anderson and Wellington 2001). Similarities between the 2 were 
confirmed by physiologic tests (Anderson and Wellington 2001). It was later concluded from 
16S and 23S rRNA comparison that Streptoverticillium could be treated as a synonym of 
Streptomyces (Anderson and Wellington 2001). 
Characteristics 
Streptomyces are Gram positive aerobic bacteria belonging to the phylum 
Actinobacteria (Stackebrandt et al. 1997). They have a DNA G+C content of 69-78 % (Anderson 
and Wellington 2001). They are in many ways similar to filamentous fungi, growing as 
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branching hyphae that form a vegetative mycelium and disperse through spores formed on 
specialized reproductive structures called aerial hyphae, which emerge from the colony surface 
into the air (Hopwood 2007). 
They are able to colonize the soil by growing as a vegetative hyphal mass that can 
differentiate into spores that assist in dispersal and persistence. The spores are a semidormant 
stage in the life cycle and can persist in soil for a long time (Kieser et al. 2000). The spores can 
withstand low nutrient and water availability unlike the mycelial stage that is sensitive to 
drought (Kieser et al. 2000). 
Chemotaxonomic and phenotypic properties are employed in defining the genus 
Streptomyces. The major emphasis is now on 16S rRNA homologies in addition to cell wall 
analysis and fatty acid and lipid patterns. Detecting the presence of LL-diaminopimelic acid (LL-
DAP) (a stereoisomer of diaminopimelic acid) as the diamino acid in the peptidoglycan is one of 
the quickest methods for identification to the genus level (Kieser et al. 2000). Many studies 
have attempted to use sequence data from variable regions of 16S rRNA to establish taxonomic 
structure within the genus, but the variation was regarded as too limited to help resolve 
problems of species differentiation (Witt and Stackebrandt 1990; Stackebrandt et al. 1991, 
1992). 
The genus Streptomyces has been subjected to several systematic studies over the past 
30 years but the identification of unknown isolates is still difficult. The International 
Streptomyces Project in 1964 established a number of standard phenotypic criteria to help in 
species characterization. However, the criteria turned out to be too minimal, and the 
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proliferation of species continued with no real attempt to compare species thoroughly with one 
another. Williams et al. (1983) came up with a numerical taxonomic system that allowed for 
comparison of many phenotypic traits concurrently. Species with similar phenotypic properties 
were clustered together and treated as a single species resulting in the reduction of the large 
number of described species (Williams et al. 1983). 
Developmental Cycle 
The life cycle of Streptomyces starts with the spores. When environmental conditions 
become favorable, a germ tube emerges from a spore, grows by tip extension and branch 
formation giving rise to a substrate/vegetative mycelium. The aerial hypha develops 2 or 3 days 
later through a process regulated by the bld genes (Kieser et al. 2000) (Figure 1).  
 
Figure 1. The life cycle of Streptomyces 
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The apical compartment of aerial hyphae forms a spiral syncytium that contains many 
tens of genomes. As the aerial hyphae become septated and mature into a spore bearing 
hyphae there is a change in shape as wall thickening occurs and gray spore pigment is 
deposited to generate desiccation-resistant spores. Sporulation septation is regulated by genes, 
whiA, B, G, H, I and J that are also required for expression of at least 1 (sigF) of 2 late regulatory 
genes, whiD and sigF. These late genes play an important role in spore wall thickening as well as 
spore pigmentation that is specified by whiE gene cluster (Kieser  et al. 2000) (Figure 1). 
Industrial Importance of Streptomyces 
Streptomycetes synthesize an amazing variety of chemically distinct inhibitors of many 
different cellular processes. These include antibiotics, fungicides, modulators of the immune 
response, and effectors of plant growth (Hopwood 2007).  
Actinomycetes produce about two-thirds of the known antibiotics and among them 80% 
are made by members of the genus Streptomyces, with other genera trailing numerically. 
Actinomycetes also account for 60% of secondary metabolites with biological activities other 
than antimicrobial, and again Streptomyces species account for 80% of these (Kieser et al. 
2000). Recent evaluations of Streptomycetes as potential antagonists of soil borne pathogens 
have focused on their ability to produce natural antifungal metabolites. Streptomyces rochei 
and Streptomyces rimosus from the chickpea rhizosphere were strong antagonists of Fusarium 
oxysporum f. sp. ciceri (Kieser et al. 2000). 
Despite extensive screening of soil samples, only a small fraction of Streptomyces taxa 
have been discovered and there is strong circumstantial evidence that the discovery of 
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previously unknown natural products occurs when novel organisms are examined in either 
established or new pharmacological screening programs (Takahashi and Omura 2003). Nine 
novel compounds were discovered from actinomycetes strains isolated using unique 
approaches such as screening soil samples at different depths and from different habitats as 
well as selective isolation (antibiotic selection) (Takahashi and Omura 2003). 
Genome 
The National Center for Biotechnology Information (NCBI) genome database lists 56 
completed genomes among greater than 50 Streptomyces species. For example, Streptomyces 
coelicolor A(3) 2 (Bentley et al. 2002), which is the most widely used laboratory strain 
(Hopwood 2007), Streptomyces avermitilis (Omura et al. 2001; Ikeda et al. 2003), and 
Streptomyces griseus IFO 13350 (Ohnishi  et al. 2008). The 8-10 Megabasepair(Mb) linear 
chromosomes comprise more than 7000 genes about 45% of which are common to the 3 
genomes: these are mostly confined to a 6.4-Mb central segment (Ventura et al. 2007). The 
chromosome and that of some other closely related bacteria represent a novel class of linear 
replicon capped by terminal proteins covalently bound at the 5’ ends (Chaconas and Chen 
2005). When the complete genome sequence of S. coelicolor was published (Bentley et al. 
2002), it was the largest known genome at 8,667, 507 bp carrying 7,825 predicted genes that 
include more than 20 clusters coding for known or predicted secondary metabolites. It still 
remains one of the largest bacterial chromosomes and complete genome sequences from other 
members of the Streptomyces genus are also large (Ikeda et al. 2003; Ohnishi et al. 2008). 
The S. coelicolor genome encodes 819 predicted secreted proteins, including 60 
proteases, 13 chitinases/chitosanases, 8 cellulases/endoglucanases, 3 amylases, and 2 pectate 
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lyases (Bentley et al. 2002). Extracellular proteins from diverse Streptomycetes hydrolyze and 
modify many different high and low molecular weight compounds or have novel function 
(Schrempf 2007).Comparison of 3 fully sequenced Streptomyces genomes revealed a core 
genome sequence for all 3 Streptomyces as well as genes specific to S. griseus including gene 
clusters for secondary metabolite production (Ohnishi et al. 2008). 
Similar to other actinomycetes strains, S. griseus has many gene clusters that contain a 
putative polyketide synthetase (PKS), nonribosomal peptide synthetase (NRPS), and PKS-NRPS 
hybrid genes (Ohinishi et al. 2008). PKSs and NPRSs participate in the synthesis of diverse 
secondary metabolites by carrying out oligomerization of small building blocks into complex 
structures. NRPSs use amino or hydroxy acids as building blocks, catalyzing the formation of 
amide or ester bonds while PKSs generate polyketide chains through the oligomerization of 
small carboxylic acids (Donadio et al. 2007). 
Genes for the synthesis of secondary metabolites probably emerged hundreds of million 
years ago (Baltz 2006). When natural product chemists analyze the genomes of Streptomycetes 
and closely related organisms, they usually find 20-30 or more gene sets for secondary 
metabolism, of which perhaps 30% are for antibiotic synthesis (Bentley et al. 2002; Ikeda et al. 
2003). 
Secondary Metabolites from Streptomyces 
At least 7000 different secondary metabolites have been discovered in Streptomyces 
isolates (Berdy 2005). These are small molecules, usually between 100 – 3000 Daltons, that are 
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biologically active outside the producer cell, many being antibiotics that inhibit enzymes and 
cellular processes (Chater et al. 2010). 
Antibiotics 
Some known antimicrobial compounds produced by Streptomyces spp. are listed in 
Table 1. 
Table 1. Bioactivity of some secondary metabolites of industrial importance from Streptomyces 
(Kieser et al. 2000; Barrios-Gonzalez et al. 2003). 
Antimicrobial compounds Activity Producer 
Cephamycin Antibacterial Streptomyces clavuligerus 
Chloramphenicol Antibacterial Streptomyces venezuelae 
Kanamycin Antibacterial Streptomyces kanamyceticus 
Tetracycline Antibacterial Streptomyces aureofaciens 
Spectinomycin Antibacterial Streptomyces spectablis 
Streptomycin Antibacterial Streptomyces griseus 
Clavulanic acid Antibacterial Streptomyces clavuligerus 
Monensin Antibacterial/Anticoccidial Streptomyces cinnamonensis 
Amphotericin Antifungal Streptomyces nodosus 
Aureofacin Antifungal Streptomyces aureofaciens 
Candicidin Antifungal Streptomyces griseus 
Nystatin Antifungal Streptomyces nourse,  
 Streptomyces aureus 
Oligomycin Antifungal Streptomyces 
diastachromogenes 
Actinomycin D Antibacterial/Antitumor Streptomyces antibioticus, 
 Streptomyces parvulus 
Mytomycin C Antibacterial/Antitumor Streptomyces lavendulae 
 
Streptomycin, the first aminoglycoside antibiotic, was discovered in the laboratory of 
S.A. Waksman more than 60 years ago (Waksman 1953). This antibiotic cured many people of 
tuberculosis and is produced industrially by S. griseus. Streptomycin belongs to the glucosides 
in which a diguanido-group is linked to a nitrogen-containing disaccharide-like compound. It 
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was found to be soluble in water and insoluble in organic solvents, such as ether, chloroform, 
and acetone. Upon hydrolysis it splits into streptidine and streptobiosamine (Waksman 1953). 
Siderophores 
Most bacteria acquire iron through secreted siderophores (nonribosomally synthesized 
small peptides with an extremely high affinity for iron (III)). Unusually, it has emerged from 
genome mining that it is common for Streptomycetes to produce more than one type of 
siderophore. Streptomyces coelicolor produces coelichelin and desferrioxamine while S. tandae 
produces desferrioxamine and enterobactin (Challis and Hopwood 2003). 
Spore Pigments 
Most Streptomycetes have pigmented spores whose color has been used as a taxonomic 
characteristic. Two chemically different types of spore pigments have been described. One 
common type which is responsible for a range of spore colors is synthesized by a type II 
polyketide synthetic route, resulting in polycyclic aromatic molecules (Chater et al. 2010). The 
other is synthesized by a type III polyketide synthetic route to generate a kind of melanin that 
seems to provide some UV protection (Chater et al. 2010). 
Research Problem 
Following the discovery and identification of strain COUK1, which was found by accident 
as a contaminant and identified via 16S rRNA sequencing, efforts have been made to isolate 
and analyze the antimicrobial compound(s) being produced by this strain. Thus this research 
tests 2 hypotheses; 
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1. Streptomyces strain COUK1 might be producing more than 1 type of inhibitory 
compound based on the difference in antibacterial activity of different culture extracts 
as well as chromatographic analysis of these extracts. 
2. Competition with another bacterium during growth could drive production of 
antibiotics. 
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  CHAPTER 2 
MATERIALS AND METHODS 
Bacterial Strains 
Streptomyces strain COUK1 was found as a contaminant on a plate in which 
Rhodococcus erythropolis was used as a test strain in a disk diffusion assay. It was found to 
show inhibitory activity against the cultured R. erythropolis strain IGTS8 (Lampson’s collection). 
Bacterial test strains used in the disk diffusion assay include Escherichia coli (Department of 
Health Sciences), Micrococcus luteus (Department of Health Sciences), R. erythropolis (strain 
IGTS8), Citrobacter freundii (ATCC 8090), Enterobacter aerogenes (ATCC 13048), Shigella 
dysenteriae (ATCC 13313), Salmonella typhi (ATCC 14028), Klebsiella pneumoniae (ATCC 13883), 
Bacillus subtillis (ATCC 6051), Staphylococcus saprophyticus (ATCC 15305), Staphylococcus 
aureus (ATCC 25923), Pseudomonas aeruginosa (ATCC 10145), and Shigella sonnei (ATCC 
29930). 
Growth Media 
Cultural characteristics were studied using nutrient agar, Mueller Hinton Agar as well as 
the following International Streptomyces Project Media (ISP) (Shirling and Gottlieb 1966), 
tryptone yeast extract broth (ISP1), yeast malt extract agar (ISP2), inorganic salts starch agar 
(ISP4), glycerol asparagine agar (ISP5), peptone yeast extract iron agar (ISP6) and tyrosine agar 
(ISP7). The colors of the aerial and vegetative mycelia were noted on these media. Production 
of soluble pigments and melanin pigment was checked on ISP2, ISP6, and ISP7 plates. 
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Carbon/sugar use was studied using the following carbon sources; glucose, arabinose, 
sucrose, fructose, rhamnose, xylose, inositol, and mannitol. 
The growth media used in antibiotic production studies included Mueller Hinton Agar, 
Rich Medium (RM), Tryptic Soy broth as well as Tryptone yeast extract broth (ISP1) and ISP4. 
Cultures COUK1 on other ISP media; ISP2, ISP5, ISP6, and ISP7 were also screened for possible 
antibiotic production.  
ISP media, Trace salt solution, Pridham and Gottlieb trace salt solution as well as media 
used in carbon use studies were prepared as described by Shirling and Gottlieb (1966). 
The components/ingredients of all media used are listed below. 
Rich Medium (RM) agar 
1) Distilled H2O        500 milliliters(ml) 
2) Dextrose         5.0 grams(g) 
3) Nutrient Broth        4.0 g 
4) Yeast Extract        0.25 g 
5) Bacto Agar        7.5 g 
Ingredients were mixed together, boiled, and then autoclaved. 
Muller Hinton (MH) agar 
1) Distilled H2O        500 mL 
2) Mueller-Hinton Broth       11.0 g 
3) Bacto agar        7.5 g 
The mixture was sterilized by autoclaving 
Nutrient Agar 
1) Nutrient agar powder      11.5 g 
2) Distilled H2O       500 ml 
The mixture was autoclaved 
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Tryptic Soy Broth 
1) Tryptic soy powder        7.5 ml 
2) Distilled H2O       250 ml 
The mixture was sterilized by autoclaving 
Trace Salts Solution  
1) FeSO4. 7H2O        0.1 g 
2) MnCl2.4H2O        0.1 g 
3) ZnSO4.7H2O        0.1 g 
4) Distilled H2O       100 ml 
The pH of the solution was adjusted to 7.0 with 1M KOH. It was then autoclaved and 
stored at room temperature. 
Tryptone Yeast Extract Broth  
1) Tryptone        1.25 g 
2) Yeast Extract       0.75 g 
3) Distilled H2O       250 ml 
Ingredients were mixed together and pH adjusted to 7.0 - 7.2 before autoclaving 
Yeast Extract Malt Extract Agar 
1) Yeast Extract         2.0 g 
2) Malt Extract       5.0 g 
3) Dextrose         2.0 g 
4) Distilled H2O        500 ml 
Ingredients were mixed together and pH adjusted to 7.0-7.3 agar was added in the 
following amount 
5) Bacto agar         10.0 g 
It was then sterilized via autoclaving. 
Inorganic Salts Starch Agar 
Solution 1:  
1) Difco soluble starch       5.0 g  
2) Distilled H2O       250 ml 
Solution 2: 
1) K2HPO4          0.5 g 
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2) MgSO4.7H2O       0.5 g 
3) NaCl         0.5 g 
4) (NH4)2SO4        1.0 g 
5) CaCO3         1.0 g 
6) Distilled H2O        250 ml 
7) Trace salts solution      0.5 ml 
The pH of this solution was adjusted to 7.0-7.4. 
Solution 1 and 2 were mixed together and then bacto agar was added as follows 
8) Bacto agar        10 g 
The mixture was then autoclaved. 
Inorganic Salts Starch Broth 
This medium was prepared just like Inorganic salts starch agar (recipe described above) 
but bacto agar was excluded. 
Glycerol Asparagine Agar 
1) L-asparagine        0.5 g 
2) Glycerol        4.0 ml 
3) K2HPO4          0.5 g 
4) Distilled H2O       500 ml 
5) Trace salts solution       0.5 ml 
pH of this mixture was adjusted to 7. 0-7. 4, and agar was added in the following 
amount 
6) Bacto Agar        10.0g 
It was then autoclaved 
Peptone Yeast Extract Iron Agar 
1) Bacto-Peptone Iron Agar, dehydrated (Difco)    18.0 g 
2) Bacto-Yeast Extract (Difco)      0.5 g 
3) Distilled H2O        500 ml 
Ingredients were mixed together and pH was adjusted to 7.0-7.2 before autoclaving. 
Tyrosine Agar 
1) Glycerol        6.0 ml 
2) L-tyrosine (Difco)         0.25 g 
3) L- asparagine (Difco)       0.25 g 
4) K2HPO4         0.25 g 
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5) MgSO4.7H2O       0.25 g 
6) NaCl         0.25 g 
7) FeSO4. 7H2O       0.005 g 
8) Distilled H2O        500 ml 
9) Trace salts solution      0.5 ml 
Ingredients were mixed together and the pH was adjusted to 7.2-7.4, bacto agar was 
then added in the following amount 
10) Bacto-Agar       10.0 g 
Medium was autoclaved. 
Pridham and Gottlieb Trace Salts  
1) CuSO4.5H2O       0.64 g 
2) FeSO4. 7H2O        0.11 g 
3) MnCl2. 4H2O        0.79 g 
4) ZnSO4.7H2O       0.15 g 
5) Distilled H2O        100.0 ml 
Solution was stored at 40C until required 
Basal Mineral Salts Agar  
1) (NH4)2SO4        1.32 g 
2) KH2PO4 anhydrous       1.19 g 
3) K2HPO4.3H2O        2.83 g 
4) MgSO4.7H2O        0.5 g 
5) Pridham and Gottlieb trace salts      0.5 ml 
6) Distilled H2O        500 ml 
Ingredients were mixed together and the pH was adjusted to 6.8-7.0, agar was added in 
the following amount 
7) Agar (Difco)       7.5 g 
Mixture was autoclaved. 
Carbon Use Media 
A 10% solution of 8 different sugars (glucose, arabinose, sucrose, fructose, rhamnose, 
xylose, inositol, and mannitol) was made by dissolving 10 g of each sugar in 100 ml of distilled 
water. The solution was then autoclaved. Freshly made sterile Basal mineral salts agar was 
allowed to cool to about 500 C, then 10 ml of a 10% sterile sugar solution was added to 100ml of 
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basal salts mineral agar to give a final concentration of 1%. The mixture was stirred and then 
poured into sterile petri dishes. 
After autoclaving, the media bottle or flask was placed in a 50o C water bath until cool 
enough to hold. Agar plates were poured into sterile plastic petri dishes. The poured plates 
were left to solidify and dry at room temperature overnight. They were then stored at 4o C until 
ready for use. Broths were stored at room temperature or at 40 C. 
Identification of Strain COUK1 
Following the discovery of a contaminant (designated strain COUK1) with inhibitory 
activity, one of the contaminant colonies was isolated and streaked out on Mueller Hinton Agar 
(medium on which contaminant was originally found). This was repeated until a pure culture 
was obtained. A colony from the pure culture was Gram stained to determine the Gram 
reaction as well as the cell morphology. 
16S rRNA Analysis 
To identify the unknown isolate, the 16S rRNA gene was amplified through the 
Polymerase Chain Reaction (PCR) and sent to University of Tennessee for DNA sequencing. A 
single colony from a 24 hours old culture was picked up with a sterile loop and dispersed in 10 
µl of sterile water. The resulting cell suspension was used as a DNA template. The template and 
other reagents were mixed in a PCR tube as shown below 
1) Double Distilled H2O       22.0 microliters(μl) 
2) 10x Buffer (Promega, Go taq flex)     10.0 μl 
3) 25 mM MgCl2 (Promega)       3.0 μl 
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4) 10 mM Deoxynucleotide Triphosphate Mix (dA, dT, dG, dC)  1.0 μl 
5) 10x Enhancer (Eppendorf)     10.0 μl 
6) 20 μM Forward primer 63F      1.25 μl 
7) 20 μM Reverse primer 1387R      1.25 μl 
8) DNA template (single bacterial colony)     1.0 μl 
9) Taq polymerase (Promega, Go taq flex)     0.5 μl 
The sequence of the forward primer, 63f, used in amplification of the 16S rRNA gene is 
5’-CAG GCC TAA CAC ATG CAA GTC-3’ and the sequence of the reverse primer, 1387r, is 5’-GGG 
CGG WGT GTA CAA GGC-3’ as according to Marchesi et al. (1998). The reaction mixture totaling 
50 µl was placed in a thermocycler and was subjected to the following cyclic temperature 
changes: 
1) 95° C for 3 minutes  
2) 95° C for 1 minute  
3) 55° C for 1 minute  
4) 72° C for 2 minutes  
5) Step 2 – 4 were repeated 29 times  
6) 72° C for 5 minutes  
After the cycling was completed, the amplification of the 16S rRNA gene was checked 
for size and concentration by subjecting the PCR reaction mix to agarose gel electrophoresis. 
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The PCR product was then cleaned using GeneClean Turbo PCR cleaning kit and then sent to the 
University of Tennessee sequencing center to obtain DNA sequences using 63F and 1387R as 
primers. The program Chromas was used to select the best segment (based on quality) of the 
sequence. The sequence was then put into the Michigan State online Ribosomal Database 
Project (RDP) (http://rdp.cme.msu.edu) for comparison and identification at the genus level. 
The database compares the query sequence to previously sequenced bacterial isolates based 
on similarity of the 16S rRNA gene sequence and will provide  20 most closely related organisms 
to the unknown 16S rRNA gene. 
Phylogenetic Analysis 
The 16S rRNA sequences of the 20 closely related species that came up following a 
sequence similarity search using the Michigan State RNA database were pulled from the 
GenBank database and aligned with that of strain COUK1 using Molecular Evolutionary Genetic 
Analysis (MEGA) software, version 5.2.2 (Tamura et al. 2011). A neighbor-joining tree was 
employed to show phylogenic relationships between strains. 
Preparation of Spore Suspension 
All growth media used in antibiotic production, cultural characteristics as well as carbon 
use studies were inoculated with spore suspensions. ISP4 broth was inoculated with a 2 cm by 2 
cm agar piece cut from a 2 days old COUK1 MH plate culture (which was inoculated with spore 
suspension).  
To make a spore suspension, 10 ml of sterile distilled water was placed on the surface of 
a 4 days old plate (Mueller Hinton agar) culture of COUK1. A sterile scalpel was used to scrape 
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cells off the agar surface suspending the cells in water. The plate was tilted slightly and a sterile 
syringe was used to suck up the resulting cell suspension from the plate. The suspension was 
then dispensed into a sterile test tube and the test tube was capped. Sterile nonadsorbent 
cotton wool was inserted into another sterile syringe. The cell suspension in the test tube was 
then poured into the syringe and filtered through the nonadsorbent cotton wool. The filtrate 
was collected in micro-centrifuge tubes that were centrifuged for about 30 minutes at 10,000 
revolutions per minute to pellet the spores. The supernatant was removed using a sterile glass 
Pasteur pipette. The pelleted spores was then resuspended in 20% or 40% glycerol and then 
stored at -200 C. 
Preparation of Seed Cultures 
Seed cultures of test organisms used in disk diffusion assays or seed culture of R. 
erythropolis used in cocultivation were prepared by picking up a single colony from a plate with 
a sterile loop and then dispersing the cells into 2.5 ml of sterile MH broth or tryptone yeast 
extract broth (for cocultivation) in a test tube (Barber 2010). The cultures were then incubated 
at 370 C for 24 hours. The seed cultures for Rhodococcus erythropolis were incubated at 300 C 
for 48 hours.  
Cocultivation 
It’s been shown that coculturing microorganisms could induce competition or 
antagonism which could bring about the accumulation or increased production of new 
secondary metabolites that are not present in the pure cultures of the producing strain (Ola et 
al. 2013; Marmann et al. 2014). 
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To determine the effect of cocultivation on strain COUK1; 250 ml of Tryptone yeast 
extract broth was inoculated with 150 µl of a R. erythropolis seed culture and was incubated for 
18-24 hours or until the optical density (OD) of the culture was 0.2-0.3. The culture was 
checked for purity by streaking, and then 2 or 3 pieces of agar (2 cm by 2 cm each) cut from a 2- 
days old COUK1 culture plate were added to the broth culture. This was incubated for about 1 
to 2 weeks or until growth of the Streptomyces was confirmed by a color change in the broth 
and streaking. The broth culture was then extracted; the extract was dried and then 
resuspended in water or methanol for sensitivity testing. The zone of inhibition of extracts from 
cocultures and pure cultures were compared. 
Extraction and Recovery of Antimicrobial Compound(S) 
Broth Extraction 
A 250 ml volume of tryptone yeast extract broth, tryptic soy broth, or inorganic salts 
starch broth was inoculated with 150 µl of spore suspension and then incubated at 300C with 
agitation at 200 revolutions/minute for 4 days. The culture was then put in Oakridge tubes and 
spun for 15 minutes at 10,000 rev/min. The spent broth was recovered by decanting it into an 
Erlenmeyer flask. A volume of 30 ml of methanol was added to the cell pellet, and the mixture 
was vortexed before centrifugation for another 15 minutes. The methanol extract was collected 
in a beaker and another 30 ml of methanol was added to the cell pellet. This was spun for 
another 15 minutes and the methanol extract was added to the one already in the beaker. The 
pooled methanol extracts were dried in a chemical hood or spun to dryness in a vacuum 
evaporator (Figure 2) 
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Figure 2. Extraction from broth culture 
The spent broth recovered was mixed with an equal volume of ethyl acetate in a 
separating funnel which was shaken vigorously every 5 minutes for about 30 minutes or the 
spent broth was mixed with an equal volume of ethyl acetate in an Erlenmeyer flask placed on a 
rotatory shaker for about an hour. The organic/ethyl acetate phase was then collected in a 
beaker and allowed to dry under a chemical hood (Figure 2). 
Agar Extraction 
Small Scale 
Sterile plates were inoculated by spreading out 50 µl of spore suspension on the agar 
surface using a sterile glass spreader. Plates were incubated at 300C for 1 week. One week old 
plate cultures were chopped into pieces/chunks and then soaked in 50 ml of methanol in a 
beaker and then covered with parafilm for 24 hours and was shaken or stirred at random times. 
The methanol extract was decanted into a separate beaker and agar chunks were soaked in 
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another 50 ml of methanol for another 24 hours. The methanol extract was then pooled with 
the previous methanol extract in the beaker. The pooled extracts were allowed to dry under a 
chemical hood (Figure 3). 
Dried extracts were resuspended in 2 ml of methanol or water and stored at 40 C for 
sensitivity testing. 
 
Figure 3. Extraction from agar/solid culture (small scale) 
Large Scale 
After the detection of an inhibitory compound in Inorganic salts starch agar, a large 
scale culture was initiated to maximize bacterial production. A volume of 100 µl of spore 
suspension was used to inoculate a 150 mm Inorganic salts starch agar plates. Twenty of these 
plates were inoculated and incubated at 300 C for a week. Each plate was then chopped into 
pieces and soaked in 100 ml of methanol for 24 hours. The methanol extracts were recovered 
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in separate beakers and the agar chunks were soaked in methanol for another 24 hours. The 
methanol extracts from all 20 plates were pooled together and allowed to dry down under a 
chemical hood. Extracts were resuspended in water, tested for activity, and stored at 40 C. 
Disk Diffusion Assay/Sensitivity Testing to Detect Antibacterial Activity 
Inhibitory activity of all extracts and chromatographic fractions were checked against all 
test organisms (listed under bacterial strains). A volume of 50 µl of a crude extract/fraction was 
applied to a paper disc and was allowed to dry. Paper discs were made from Whatman Blotting 
Paper GB004 with the aid of a standard hole punch and sterilized by autoclaving. A seed culture 
of each test strain with turbidity adjusted to a 0.5 McFarland standard was swabbed on Mueller 
Hinton agar and then paper discs soaked with 50 µl of extracts/fractions were placed on the 
swabbed agar surface. The plates were incubated overnight at 370 C for 24 hours. Plates with R. 
erythropolis were incubated at 300 C for 48 hours. Discs showing a halo/clear zone of no growth 
indicate the possible presence of an inhibitory compound. 
Silica Gel Column Chromatography 
Size exclusion chromatography allows compounds to be separated based on size. Thirty-
two grams of silica gel resins (mesh 70-230) was soaked in water to make a free flowing slurry 
that was then poured into a 1.8 cm (width) by 50 cm (height) column to a give a bed volume of 
about 100 ml. The water was slowly drained to obtain a well packed column. Crude extract 
from ISP4 large scale culture (same as large scale agar extraction described above) was dried 
and resuspended in 1 ml of water; this was then loaded gently on top of the column using a 
Pasteur’s pipette and was allowed to drain into the column before water was applied for 
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elution. Fractions of 2.5 ml each were collected and tested for activity until the last active 
fraction was collected. 
XAD-2 Column Chromatography 
In this type of affinity chromatography, aromatic and hydrophobic compounds of 
interest are expected to bind to the resin that is then eluted using an organic solvent or a 
suitable buffer. In this case some of the spent broth from broth cultures were reserved and 
subjected to XAD-2 column chromatography (Figure 2) with the aim of recovering the inhibitory 
compound contained in spent broths. Fifty grams of XAD-2 resin was soaked in water overnight 
and packed in a column (3.5 cm (width) by 50 cm (height)) to make a bed volume of 
approximately 80 ml. Spent broths showing activity were passed through the column and were 
allowed to drain out of the column at a flow rate of 1 drop/second to allow for retention of 
inhibitory compound(s). The eluate was saved. The column was then washed with about 200 ml 
of distilled water; the water eluate was also saved. The column was then eluted with about 100 
ml of methanol. Fractions of 25 ml each were collected. All saved eluate/fractions were tested 
for inhibitory activity. Methanol fractions were dried in a vacuum evaporator and then 
resuspended in 2 ml of methanol or water for sensitivity testing. 
Thin Layer Chromatography (TLC) 
TLC silica gel 60 F254 plates from Merck KGaA, Germany were employed in the 
separation of crude extracts and chromatographic fractions. Extracts in varying amounts were 
spotted on the baseline which is 1 cm from the bottom of a plate cut to a height of 15 cm and a 
varying width (depending on the number of samples to be analyzed). This was then developed 
using different solvent systems that allowed best separation of the extract. The plates were 
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removed from the solvent system when the solvent front reached about 1cm from the top of 
the plates. The plates were dried and then observed under UV light for bands or spots. Extracts 
from ISP4 agar or broth were developed on TLC plate using butanol: acetic acid (1:1), butanol: 
acetic acid: water (6:4:1), propanol: acetic acid: water (5:1:3) as these were the solvent systems 
that allowed the separation of these extracts. Extracts from other media were developed using 
chloroform: methanol: 25% NH3 (42.5:7:0.5) (Johdo et al. 1991). 
Bioautograghy 
Following TLC bioautography was used to detect active compounds on TLC strips. TLC 
strips were laid on the surface of a Mueller Hinton agar plate inoculated with M. luteus for 
about 2-10 hrs at 40 C to allow compound(s) on the strip  to leach from the TLC strip into the 
agar. The strips were removed and the plates were  incubated at 370 C overnight.  
High Pressure Liquid Chromatography (HPLC) 
HPLC was employed in the purification of the inhibitory compound. Active fractions 
from silica gel columns were pooled, dried, resuspended in 0.5ml of water, filtered using a 
0.45um filter, and loaded/injected into an HPLC set up with a Waters 7.8 mm x 300 mm 
Novapak HR C-18 hydrophobic column as the stationary phase and degassed distilled H2O and 
methanol as the mobile phases or eluents. Due to the polar nature of the inhibitory compound, 
a 2% methanol program was used in which a linear gradient system is produced that would 
allow compounds contained in the injected sample to separate and elute as the methanol 
concentration increases from 2% to 100% in the mobile phase. The presence of compounds in 
the sample were detected with the aid of a UV light (254 nm). Ninety fractions were collected 
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and tested for inhibitory activity. Fractions containing inhibitory compound were compared to 
the chromatogram. 
Ion Exchange Chromatography 
Normal phase chromatography was carried out using Alltech’s HEMA IEC BIO 1000 DEAU 
HPLC column as the stationary phase. This hydrophilic column allows the binding and 
separation of hydrophilic compounds. Active silica gel column fractions were pooled, dried, and 
resuspended in water. A volume of 0.5 ml of this was injected into the HPLC. A gradient elution 
was employed using 0.05 M ammonium acetate (A) and 0.5 M ammonium acetate (B), pH 5.0, 
that is, 100% of A for 10 minutes, 100% A to 100% B in 10 minutes and then 100% of B for 10 
minutes with the flow rate at 1 ml/minute. Thirty fractions were collected and tested for 
activity. 
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CHAPTER 3 
RESULTS AND DISCUSSION 
Strain COUK1 
Strain COUK1 appeared as a contaminant on a Mueller Hinton agar plate in the form of 
tiny colonies producing zones of inhibition against a culture of R. erythropolis, which was used 
as a test strain in a disk diffusion assay (Figure 4). The contaminant appeared while testing 
chromatographic fractions of extracts from Rhodococcus Strain MTM3W5.2 against R. 
erythropolis for inhibitory activity.  
 
Figure 4. Contaminant (strain COUK1) discovered on a plate. Red arrow shows a tiny dark colony with a 
zone of inhibition against the indicator organism, Rhodococcus erythropolis. 
Identification of Strain COUK1 
At the moment this strain was found, it wasn’t known as Streptomyces; therefore, a 
colony was streaked on MH agar to produce isolated colonies. One of the resulting colonies was 
streaked out again to ensure a pure culture; 16s rRNA sequencing was then carried out on one 
of the isolated colonies. 
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16S rRNA Sequence Analysis 
The 16S rRNA gene amplified via PCR resulted in an approximately 1.3 kilobasepairs (kb) 
fragment (Figure 5). The amplified DNA was purified and sequenced. About 1299 bp of the 
sequence was put into an online database (http://rdp.cme.msu.edu) and compared to other 
bacterial isolates. The sequencing result shows that COUK1 belongs to the phylum 
Actinobacteria, the family Streptomycetaceae and the genus Streptomyces (Figure 6). Because 
species identification cannot be determined by 16S rRNA data alone, phylogeny as well as 
cultural and biochemical properties were employed to narrow down to a possible species. 
 
Figure 5. PCR amplified 16S rRNA gene. Lane 1: Molecular weight marker i.e. λDNA cut with HindIII. Lane 
2: amplified DNA fragment of ~1.3 kb from a single colony of COUK1. 
Williams et al. (1983) designed a numerical taxonomic system based on phenotypic 
traits in which Streptomyces species with similar traits were clustered around a particular 
species (within the group) in a bid to reduce the large number of described Streptomyces 
species because many of these species were found to be synonymous. For example, 
Streptomyces flavoviridis and Streptomyces glaucescens were both treated as S. glaucescens 
and assigned to cluster 28 or the S. glaucescens group. 
2 1 
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Figure 6. 16S rRNA sequencing results confirmed the genus of the unknown isolate is Streptomyces 
 
Similarly, some of the species listed in the 16S sequencing result (Figure 6) such as 
Streptomyces virginiae and Streptomyces lavendulae have been described as members of the 
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Streptomyces lavendulae group or cluster 61 and may be treated as S. lavendulae (Williams et 
al. 1983). 
Phylogenetic Tree 
A neighbor-joining tree was employed to show phylogenetic relationships between 
strain COUK1 and other Streptomyces neighbor (Figure 7). 
 
Figure 7. Neighbor joining tree based on 16S rRNA sequences showing phylogenetic relationship 
between strain COUK1 (red arrow) and other Streptomyces neighbors 
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The 16S gene sequence of strain COUK1 was found to pair up with (match) that of 
Streptomyces cinnamonensis strain JCM 4019 (Figure 7). It’s important to note that a partial 
sequence of the 16S rRNA gene of strain of COUK1 was used and the closest matches were to 
the partial sequences. Also, different Streptomyces species may have nearly identical 16S 
sequences. The low bootstrap values (that is values < 50) observed at some nodes indicates 
little support for branching patterns. These factors may affect the accuracy of the phylogeny. 
COUK1 Phenotypic Characteristics 
Strain COUK1 appears as Gram positive filaments in a standard Gram stain reaction 
(Figure 8B). We suspected the contaminant was Streptomyces as they are known to form 
branching filaments like fungi. This was later confirmed by 16S rRNA sequencing. Based on cell 
morphology it may be classified as Retinaculum-Apertum i.e. Streptomyces whose 
hyphae/filaments appear as open loops or hooks (Pridham et al. 1958). When cultured on MH 
agar it produces a very dark pigmentation (Figure 8A). Other cultural characteristics such as 
color of aerial and vegetative hyphae as well as pigmentation were observed on ISP media and 
nutrient agar (Figure 9) 
 
Figure 8. (A); Colonies of strain COUK1 producing dark pigmentation on Mueller Hinton 
Agar. (B); Microscopic examination of Strain COUK1 appearing as gram positive filaments. 
 
 
A B 
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Cultural Characterization of Strain COUK1 
Cultural characteristics of strain COUK1 were studied using the method described by 
Shirling and Gottlieb (1966). Morphological and cultural properties were observed on Nutrient 
agar and ISP media (Figure 9). 
Figure 9. Pigmentation of aerial and vegetative mycelium of strain COUK1 on different growth media. a 
indicates gray, N.A. indicates not applicable. 
These properties were compared to those of already known Streptomyces species for 
the purpose of identifying this isolate to the species level. Pigmentation on ISP media is one of 
the main criteria used in identifying and classifying Streptomyces. The presence of black 
pigmentation on peptone-yeast extract iron agar (ISP6) suggests the production of melanin by 
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strain COUK1. Melanins are a diverse group of pigments produced in living organisms. They are 
products of oxidative polymerization of phenolic substances and thus form a group of 
biopolymers (Plonka and Gabracka 2006). Types of melanins include eumelanins (black or 
brown), pheomelanins (yellow to red), and allomelanins (various colored 
dihydroxynaphthalene(DHN)-melanins) (Plonka and Gabracka 2006). The production of melanin 
has been linked to enzymes such as tyrosinases and polyketide synthetases (PKSs) that are 
associated with secondary metabolism and pigmentation in bacteria (Plonka and Gabracka 
2006). Melanins are known to play a role in protecting an organism from UV radiation and 
could also serve as a virulence factor by protecting organisms from superoxide anions during 
phagocytosis. They can also function as electron carriers/acceptors making it possible to 
produce energy in a way similar to oxidative phosphorylation but under anaerobic conditions 
(Plonka and Gabracka 2006). Streptomyces species belonging to the Streptomyces lavendulae 
group or cluster 61 are known to produce melanin in peptone yeast extract iron agar (Williams 
et al. 1983). Pink pigmentation on Tyrosine agar (ISP7) was also observed.  
The presence of these pigments also indicates secondary metabolism is active in this 
strain. Many pigments, like antibiotics, are produced by enzymes such as polyketide 
synthetases (PKSs) and nonribosomal peptide synthetases (NRPSs) (Bentley et al. 2002). 
However, more than one Streptomyces sp. might show similar pigmentation properties and 
production may vary with environmental factors, thus these properties may not be very reliable 
as a means for species identification. 
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Sugar/Carbon Use Pattern 
The ability of strain COUK1 to use different carbohydrates for growth can be used to 
identify different species by culturing it on media containing different sugars. These include 
glucose, arabinose, sucrose, fructose, rhamnose, xylose, inositol, and mannitol. Growth or 
colony formation in the presence of a particular sugar indicates a positive reaction (Table 2). 
Sanchez-Marroquin (1958) observed the carbon use pattern of 5 strains of Streptomyces 
lavendulae, 2 strains of Streptomyces virginiae, and 3 strains of Streptomyces cinnamonensis ( 
all of which belong to the Streptomyces lavendulae group), and the variation of sugars used 
among strains was noted. The carbon use pattern of these strains was compared to that of stain 
COUK1 (Table 2).  
Table 2. Carbon use pattern of 3 species of the S. lavendulae group compared to that of strain 
COUK1. 
a: - indicates no growth, + indicates good growth, +/- indicates partial/poor growth. ‘to’ indicates 
variation among strains examined. Blank cells mean result was not published by source or experiment 
was not conducted (Sanchez-Marroquin 1958; Bergey and Holt 1977). 
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Based on its pattern of sugars used for growth, strain COUK1 appears most similar with 
strains of S. cinnamonensis except it partially uses inositol (Table 2). Bergey and Holt (1977) also 
observed the carbon use pattern for members of the S. lavendulae group and had a result 
similar to that of Sanchez-Marroquin (1958) (Table 2). 
Antibiotic Production Studies 
Antibiotic production was initially studied using MH agar, Rich Medium (RM) agar, and 
Tryptic soy broth in an attempt to find suitable media for growth and antibiotic production. 
Later we wanted to see if the ISP media primarily used in species classification would also be 
suitable for antibiotic production or have effect on expression with the hope that growing 
COUK1 on different types of media would induce the production of different compounds, 
possibly with different inhibitory activity. Thus, cultures grown on these media were extracted 
and the extracts tested for inhibitory activity.  
Extract from ISP4 was found to show inhibitory activity against all 3 test strains, that is, 
E. coli, M. luteus, and R. erythropolis and it had a stronger inhibitory activity than extracts from 
other media as indicated by very wide zones of inhibition (Figure 10). This strong antibacterial 
activity suggests the possible ability of this strain (when grown on ISP4) to produce a different 
inhibitory compound or overexpress what it produces compared to other media and as a result 
the analysis of ISP4 extracts was prioritized. Extract from the broth culture, inorganic salts 
starch broth, also showed similar antibacterial activity (Figure 10). Initially agar cultures were 
extracted with ethyl acetate and methanol. But ethyl acetate extracts showed no activity (data 
not shown). Thus, all agar cultures were extracted with methanol. 
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Figure 10. Table showing different extraction methods, inhibitory activity of extracts from different 
media and TLC analysis of the extracts 
 
For broth cultures, spent broths (liquid portion of broth cultures recovered via 
centrifugation) as well as extracts from spent broth and cell pellet were tested for activity. Also 
methanol extracts of cell pellets showed a wider spectrum of activity compared to the ethyl 
acetate extracts. Spent broth from tryptone yeast extract broth was found to show activity 
against E. coli, M. luteus, and R. erythopolis. However, ethyl acetate extract of the spent broth 
only showed activity against M. luteus (Figure 10). This suggests that ethyl acetate is leaving 
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some inhibitory compound behind in the spent broth as different compounds will exhibit 
different polarity and would come out with an organic solvent of similar polarity in a solvent 
extraction procedure. This result indicates the possible presence of more than one inhibitory 
compound. Extracts from different media were also analyzed via Thin Layer Chromatography 
(TLC) to allow for separation of crude extracts into detectable spots.  
TLC and Bioautography 
Using TLC and bioautography, it may be possible to isolate and even purify antibiotic-like 
compounds based on the separation of visible spots on TLC plates. Crude extracts from COUK1 
grown on Inorganic salts starch agar (ISP4) were separated by TLC and the spots on TLC strips 
were tested for inhibitory activity by laying the TLC strips on top of a Mueller Hinton agar plate 
inoculated with a test strain for about 10 hours to allow the compounds to leach into the agar 
from the strip. The TLC strips were removed and plates were incubated (Figure 11). Plates were 
observed for a clear zone of inhibition which represents the possible presence of inhibitory 
compounds. The Butanol: Acetic acid solvent systems moved only some of the active 
compound(s) away from the baseline (where the crude extract was spotted) leaving most of 
these compounds behind at the baseline (Figure 11). 
The Propanol: Acetic acid: water solvent system moved all the active compound(s) away 
from the baseline but the band resolution or compound separation was very poor on the TLC 
strips when observed under UV light (see Figure 11). 
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Figure 11. Detection of active compound(s) in crude extracts from inorganic salts starch agar on TLC 
strips via Bioautography. Red arrows indicate the baseline where extract was spotted; blue arrows 
indicate other active spots (isolated compound(s)). 
Purification of Inhibitory Compound from Cultures Grown on ISP4 
Silica Gel Column Chromatography 
Twenty plates grown with strain COUK1 were harvested and extracted. The pooled 
extract was subjected to gel filtration through a silica gel column eluted with water due to the 
hydrophilic nature of the compounds, as previous attempts to elute the column with 
methanol:water solvent systems or propanol:water solvent systems were not very successful. 
Individual fractions collected were tested for activity. Fractions containing inhibitory 
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compound(s) were obtained in column fractions 11 to 22. (Figure 12). These fractions were 
pooled together, spun to dryness, and resuspended in water for further purification by High 
Pressure Liquid Chromatography (HPLC). 
Figure 12. Inhibitory activity of silica gel column fractions 
Silica gel column fractions were screened against 3 different indicator organisms with 
the hope of seeing a difference in activity among column fractions that would suggest the 
presence of different inhibitory compounds. Fractions 11-22 showed similar inhibitory activity 
against all 3 test organisms. 
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High Pressure Liquid Chromatography 
Silica gel column fractions (11-22) showing activity were pooled, dried, and resuspended 
in 1 ml of distilled water. This was injected into a C-18 hydrophobic column and eluted using a 
2% methanol program (Figure 13).  
 
 
 
Figure 13. (A); HPLC-C18 analysis of pooled active fractions from a silica gel column. Inhibitory 
compound(s) contained in fractions 5 and 6 corresponding to the two unseparated peaks Indicated by 
red arrows. (B); Inhibitory activity of HPLC fractions 5 and 6 
A 
B 
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The compound(s) in the extract are expected to elute as methanol content increases 
from 2% to 100% in the mobile phase. Fractions were tested for activity against M. luteus, E. 
coli, and R. erythropolis.  Active compound(s) came off early, with 2 unseparated peaks 
corresponding to fractions 5 and 6 (Figure 13).  
The HPLC chromatogram (Figure 13) suggests that the inhibitory compound is 
hydrophilic in nature since it’s not binding to the C-18 hydrophobic column. 
Ion Exchange Chromatography (HPLC) 
Due to the hydrophilic nature of the inhibitory compound(s), a normal phase 
chromatography was carried out using HEMA IEC BIO 1000 DEAU HPLC column. 0.05 M 
ammonium acetate and 0.5 M ammonium acetate (pH 5.0) was used for gradient elution. The 
30 fractions collected were tested for activity. Inhibitory activity was found in fractions 6-9 and 
in fractions 27 and 28. Better peak separation and retention of the inhibitory compound was 
observed with ion exchange chromatography compared to HPLC-C18 analysis (Figure 14).  
Ion exchange chromatography appeared to produce 2 separate peaks. The first peak 
(Peak 1) at fractions 6-9 showed inhibitory activity against all 3 indicator bacteria. The second 
peak (Peak 2) at fractions 27 and 28 showed inhibitory activity only against M. luteus. This 
suggests there are 2 different compounds (Figure 14). 
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Figure 14. (A); HPLC chromatogram showing a peak corresponding to fractions 6-9 and a peak at 27 and 
28. Red boxes indicate peaks with inhibitory activity (B); Inhibitory activity of fractions 6-9 against M. 
luteus. (C); Inhibitory activity of fractions 27 and 28 against M. luteus. (D); Inhibitory activity of fractions 
6-9 against E. coli. (E); Inhibitory activity of fractions 6-9 against R. erythropolis 
A 
B 
 
C 
 
D 
 
E 
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Fractions 6-9 (Peak 1) were pooled together and dried down to approximately 1 ml, 
fractions 27 and 28 (Peak 2) were treated likewise. Peak 1 and 2 were then checked for possible 
inhibitory activity against some other human pathogens (Figure 15). 
 
Figure 15. Inhibitory activity of Peak 1 and 2 against some human pathogens 
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Pooled fractions 6-9 (Peak 1) showed inhibitory activity against Citrobacter freundii, 
Enterobacter aerogenes, Shigella dysenteriae, Salmonella typhi, Klebsiella pneumonia, 
Escherichia coli, Bacillus subtillis, Staphylococcus saprophyticus, and Rhodococcus erythropolis 
(Figure 15) but was not active against Staphylococcus aureus, Pseudomonas aeruginosa, and 
Shigella sonnei (Data not shown). Pooled fractions 27 and 28 (Peak 2) showed inhibitory activity 
only against M. luteus and S. saprophyticus (Figure 15). 
This result (Figure 15) suggests that the inhibitory compound at the first peak (Peak 1) 
may have a broad spectrum of activity against gram positive and gram negative bacteria 
pathogens compared to the inhibitory compound at peak 2 that has only shown inhibitory 
activity against M. luteus and S. saprophyticus. 
The activity of our isolated compounds was compared to the activity of known 
compounds from some members of S. lavendulae group (Table 3). Virginiamycin, a macrolide 
antibitiotic (made up of virginiamycin S1 and virginiamycin M), has been reported from S. 
virginiae and it usually inhibits Gram positive bacteria. Most Gram negative bacteria are not 
susceptible with the exception of Brachyspira hyodesentariae, a Gram negative pathogen that 
causes swine dysentery (Cocito 1979; Molinero et al. 1989) (Table 3). Streptothricin, an 
aminoglycoside from S. lavendulae, is known to inhibit different Gram positive and Gram 
negative bacteria as well as mycobacterium. It also has antifungal properties (Waksman et al. 
1951). Two quinone antibiotics, Saframycin (Aria et al. 1985) and Mitomycin C (Mao et al. 
1999), have also been reported from S. lavendulae and are mainly used in cancer treatment. 
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But mitomycin c also has bactericidal effects on Gram positive and Gram negative pathogens 
(Ueda et al. 1983; Lorian 2005) (Table 3).  
Table 3. Activity of known bioactive compounds from some members of S. lavendulae group 
compared to that of strain COUK1 
 
Monensin, a polyether ionophorous (form complexes with monovalent cations) 
antibiotic from S. cinnamonensis, has been reported to inhibit only Gram positive bacteria. It is 
also reported to inhibit Plasmodium falciparum (Malaria parasite) and can also be used to treat 
coccidiosis (Lowicki and Huczynski 2013) (Table 3). However, strain COUK1 (found similar to S. 
cinnamonensis (Figure 7; Table 2)) produces a compound(s) (peak 1, Figure 15) active against 
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both Gram positive and Gram negative bacteria, an antibacterial activity similar to those of 
streptothricin and mitomycin c. Thus, COUK1 could be a unique strain of S. cinnamonensis. The 
inhibitory compound at peak 1 from COUK1 has not been screened against protozoa, fungi, and 
cancer cell lines, thus, its bioactive potential might not be fully known.  
Coculture 
Cocultivating 2 or more organisms together better mimics natural ecological conditions 
where microorganisms coexist in microbial communities. Many biosynthetic genes are not 
expressed under routine laboratory conditions. The competition experienced during 
cocultivation has been shown to induce the expression of biosynthetic genes that are silent in 
pure culture conditions (Marmann et al. 2014). To see what effect competition would have on 
strain COUK1’s secondary metabolism, it was cocultivated with R. erythropolis (Figure 16). 
 
Figure 16. Comparison of inhibitory activity of extracts from pure and coculture 
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Extracts from the coculture were tested for inhibitory activity and the activity was 
compared to that from pure (COUK1) culture. The spent broth from the coculture produced a 
slightly bigger zone of inhibition against M. luteus and R. erythropolis compared to that from 
the pure culture. There was no significant difference in the activity of methanol extract of cell 
pellet from pure or coculture (Figure 16). 
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CHAPTER 4 
CONCLUSION 
Streptomyces are known to be prolific sources of novel secondary metabolites with 
diverse biological activities such as antibacterial, antifungal, and other pharmacologically active 
substances. Genomic sequencing revealed an additional 30 gene clusters or genes for putative 
secondary metabolites in S. griseus apart from the already known gene clusters for 
streptomycin, grixazone, and other known secondary metabolites from this organism (Ohnishi 
et al. 2008). Some actinomycetes produce more than one antibiotic substance (Waksman 
1946). Antibiotics, including actinorhodin, undecylprodigiosin, calcium dependent antibiotic, 
and methylenomycin A, have been reported from Streptomyces coelicolor A3(2) (Hobbs et al. 
1992). 
The definition of species in the Streptomyces taxonomy has not been resolved due to 
the variety of morphological, cultural, and biochemical properties observed at the intra and 
inter species level (Anderson and Wellington 2001). After the discovery of antibiotics from 
Streptomyces in the 1940s, the screen for novel compound increased resulting in the need for 
patenting novel bioactive compounds. This in turn resulted in over-classification of 
Streptomyces. Described Streptomyces species increased from 40 to about 3000. Many of these 
species were considered synonyms as they were proposed based on trivial differences in 
morphological and cultural characteristics (Williams et al. 1983).  
In 1964 the International Streptomyces Project (ISP) was established to come up with 
standard criteria for species determination to reduce the number of poorly described 
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synonymous species. They described criteria that took into consideration properties like spore 
chain morphology, color of aerial and vegetative hyphae, production of soluble pigments, 
production of melanin, and use of carbon sources. More than 450 species were redescribed 
with these criteria. The ISP was unable to establish an identification scheme but rather provide 
standard methods by which identification can be achieved (Anderson and Wellington 2001). 
Williams et al. (1983) employed phenetic characters (which include morphology, pigmentation, 
antimicrobial activity, biochemical tests, degradative tests, antibiotic resistance, growth tests, 
use of carbon, and nitrogen sources) in designing a numerical taxonomic approach that led to 
reduction in the number Streptomyces species. This approach allowed the simultaneous 
evaluation of a large number of phenotypic traits. About 400 Streptomyces strains were 
clustered based on similarities obtained from phenetic tests. At a 77.5% simple matching 
coefficient (SSM) ( a measure of distance or similarity), 19 major, 40 minor, and 18 single strain 
clusters were described with most of the minor clusters consisting of fewer than 5 strains. For 
example, Cluster 13 consists of S. aureofaciens and S. roseofulvus, both considered to be S. 
aureofaciens. Major clusters varied in size from 6 to 71 strains. Each of these clusters was 
treated as a single species despite the diversity observed within some clusters (to help resolve 
the problem of overclassification/overspeciation of the genus) and is thus regarded as a species 
group (Anderson and Wellington 2001). 
Application of 16S rRNA sequence analysis to Streptomyces phylogeny has helped study 
relationships at the genus, species, and strains level. Comparison of 16S rRNA sequences of the 
representatives of the major cluster groups defined by Williams et al. (1983) supports the 
groups’ phenotype based taxonomy (Anderson and Wellington 2001). Determining a 
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correlation between genotypic and phenotypic characteristics will result in a better 
understanding of Streptomycetes taxonomy. Despite the increasing applications of molecular 
techniques to Streptomycetes taxonomy, many of the clusters defined using numerical 
taxonomy are retained. However there’s a need to emphasize which traits can be used as 
certain phenotypes such as antibiotic production and antibiotic resistance are not suitable as 
they might result from horizontal gene transfer events (Anderson and Wellington 2001).  
Strain COUK1 was discovered as a contaminant. Results from 16S rRNA analysis and 
other phenotypic/biochemical test (morphology, pigmentation, and sugar use pattern) revealed 
it is a member of the Streptomyces lavendulae group. Our result revealed that strain COUK1 
produces inhibitory compound(s) in broth and agar. The production of antibiotics by 
Streptomyces in solid cultures is known to coincide with the development of the aerial hyphae. 
The bald (bld) genes involved in formation of aerial hyphae have also been linked to antibiotics 
production (Kieser et al. 2000). In liquid culture antibiotic production is linked to stationary 
phase and it is assumed to result from nutrient limitation (Bibb 2005). This shows that the 
production of antibiotics by Streptomyces is growth phase dependent. Crude extracts recovered 
from solid and liquid cultures were tested for inhibitory activity and spotted on TLC strips for 
separation into detectable spots. In most cases TLC analysis did not produce clear detectable 
spots or bands that correspond to inhibitory activity (Figures 10 and 11). 
 We hypothesized that Streptomyces strain COUK1 might be producing more than one 
type of inhibitory compound based on differences in antibacterial activity of different culture 
extracts as well as chromatographic analysis of these extracts. There’s evidence that ethyl-
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acetate is leaving some inhibitory compound behind in spent broth during solvent extraction as 
spent broth from tryptone yeast extract broth culture showed a wider spectrum of inhibitory 
activity compared to the ethyl-acetate extract. This suggests the presence of 2 or more types of 
inhibitory compounds on the basis of polarity.  
The analysis of extracts from inorganic salts starch agar (ISP4) was prioritized because it 
showed the strongest inhibitory activity compared to extracts from other media. Carbon 
sources are one of the main factors involved in the regulation of secondary metabolism 
(Sanchez et al. 2010). Several sugars are commonly used as carbon sources for growth and 
secondary metabolite production, but some of them are preferred by Streptomyces and this 
usually associated with catabolite repression (Sanchez et al. 2010). Starch and glycerol were 
found to increase the production of antibiotics in batch cultures of S. violatus compared to 
glucose and other carbon sources (Hassan et al. 2004). Also culturing Streptomyces on a 
chemically defined medium could put it under physiological stress and slow down its growth, 
promoting secondary metabolism (Demain and Fang 1995). All these factors might explain the 
reason why COUK1 expresses a strong inhibitory compound(s) in a minimal/chemically defined 
medium like ISP4.  
The crude extracts from ISP4 were purified and separated into constituent compounds 
using different chromatographic analysis. The observation of 2 different peaks (with different 
retention time i.e. one observed early and the other late (Figure 14A)) with inhibitory activity 
following ion exchange chromatographic (HPLC) analysis of ISP4 extracts also corroborates the 
hypothesis that COUK1 produces more than 1 type of inhibitory compound because the first 
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peak showed a wide spectrum of activity against both Gram positive and Gram negative 
bacteria whereas the second peak showed activity against only 2 Gram positive bacteria; M. 
luteus and S. saprophyticus (Figure 15). 
Mass spectrometry and Nuclear Magnetic Resonance will be required to determine the 
elemental composition and structures of the inhibitory compounds at peak 1 and 2 (Figure 14). 
However, in terms of antibacterial activity the compound from COUK1 at peak 1 might be 
identical to streptothricin (an aminoglycoside) and mitomycin c (a quinone antibiotic) from S. 
lavendulae (Table 3). Bacteria resistant to streptothricin and mitomycin c might also be used in 
screening the compound at peak 1 from strain COUK1. 
Standard methods or chromatographic techniques used in isolating and identifying 
known broad spectrum compounds such as streptothricin and mitomycin c from S. lavendulae 
cultures can be applied to crude extracts from COUK1 cultures and the results can be compared 
to standard results of the known compounds for possible similarity. Another way to find out if 
the compound at peak 1 has been reported from members of S. lavendulae group would be to 
identify and sequence the gene involved in the synthesis. This can then be compared to genes 
responsible for the synthesis of compounds like streptothricin, mitomycin c and other broad 
spectrum antibiotics from members of S. lavendulae group. 
To see what effect competition would have on antibiotic production, strain COUK1 was 
cocultured with R. erythropolis (another actinobacteria). Spent broth from the coculture 
showed slightly stronger activity against M. luteus and R. erythropolis compared to spent broth 
from COUK1’s pure culture. It’s been found that coculturing forces direct interaction between 
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organisms and could result in increased production of known compounds or stimulate the 
expression of silent genes involved in the synthesis of novel secondary metabolites (Ola et al. 
2013; Marmann et al. 2014). For example, pestalone, a new antibiotic was discovered from a 
coculture of the marine fungus Pestalonia sp. with an unknown alpha-proteobacterium, CNJ-
328 (Ola et al. 2013). Similarly, Streptomyces endus was found to produce the new antibiotic 
alchivemycin A when cocultured with mycolic acid-producing bacterium, Tsukarella pulmonis 
(Marmann et al. 2014). It’s been shown that intimate cell-to-cell interaction between 
cocultivated organisms is required to modulate the genes of the secondary metabolite 
producing strain (Marmann et al. 2014).  
There was no significant difference in inhibitory activity of coculture extracts of COUK1 
and R. erythropolis compared to COUK1’s pure culture extracts probably because R. erythropolis 
dies 3 or 4 days after introducing strain COUK1 to the culture due to COUK1’s inhibitory activity 
and might not have stayed long enough to stimulate COUK1’s biosynthetic ability. The influence 
of competition on the antibiotic producing ability of strain COUK1 needs to be further 
investigated by cocultivating it with other bacteria. 
Several factors have been linked to the regulation of antibiotic production. These 
include but not limited to nutrients source (carbon source, nitrogen source, phosphorus source) 
and amount, growth rate, and phase, as well as antagonism/competition. The mechanism of 
regulation of a secondary metabolism is complex, but the gene clusters involved are known to 
be manipulated or steered by different physiological and environmental conditions (Hobbs et 
al. 1992; Bibb 2005). 
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